Home › Employers › Premium Health, Inc.
Premium Health, Inc.: H-1B salaries and sponsorship
Premium Health, Inc. filed 5 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 5. Median offered salary: $300,000.
Does Premium Health, Inc. sponsor H-1B visas?
Premium Health, Inc. filed 5 labor condition applications in fiscal years 2023–2026, the latest submitted on Apr 16, 2026. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.
Salaries by job title
| Job title | LCAs | Median salary |
|---|---|---|
| Obstetrician/Gynecologist | 5 | $300,000 |
Applications by fiscal year
| Fiscal year | LCAs | Median salary |
|---|---|---|
| FY2023 | 3 | $300,000 |
| FY2026 | 2 | $330,000 |
Prevailing wage levels
The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.
Where the jobs are
Occupations
Latest applications
| Job title | Base salary | Location | Submitted | Start date | Status |
|---|---|---|---|---|---|
| Obstetrician/Gynecologist | $330,000 | Brooklyn, NY | Apr 16, 2026 | Aug 1, 2026 | Certified |
| Obstetrician/Gynecologist | $330,000 Level II | Brooklyn, NY | Mar 16, 2026 | Aug 1, 2026 | Certified |
| Obstetrician/Gynecologist | $300,000 | Brooklyn, NY | Jul 24, 2023 | Aug 1, 2023 | Certified |
| Obstetrician/Gynecologist | $300,000 | Brooklyn, NY | Jul 3, 2023 | Aug 1, 2023 | Certified |
| Obstetrician/Gynecologist | $300,000 | Brooklyn, NY | Jun 15, 2023 | Sep 5, 2023 | Certified |
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).